Figure 2 shows that OVX significantly increased protein concentration of IL-1β in the serum. WSP-AbM treatment decreased the level of IL-1β by 27.3% as compared to the OVX group (P < 0.05). As shown in Figure 2, the levels of TNF-α elevated significantly after OVX-induced osteoporosis. WSP-AbM suppressed this response (P < 0.05). The gene discussed is IL1B; the disease is osteoporosis.